Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Grifols SA

Grifols SA (GRF SM)

79
Analysis
Health Care • Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullish•Grifols SA
•14 Nov 2024 17:28

Brookfield Refinances Grifols' Debt

Brookfield has secured an €11 billion loan to refinance Grifols’ debt, paving the way for a potential takeover and significant control over...

Share
bearish•Grifols SA
•28 Oct 2024 22:45

Brookfield Delays Its Takeover Bid for Grifols for a Second Time

Brookfield’s acquisition bid for Grifols has been delayed for a second time due to funding issues, raising investor concerns.

Share
bullish•Grifols SA
•20 Sep 2024 16:30

Brookfield/Grifols: Recap and Analysis of Latest Developments

Since Brookfield's July 8 takeover interest for Grifols was announced, the situation has become complicated, with unclear pricing, funding...

Share
bullish•Grifols SA
•30 Aug 2024 13:15

Brookfield Explores Sovereign Funds for Grifols Takeover Bid

Press reports Brookfield is seeking support from sovereign wealth funds, including those from Abu Dhabi (ADQ) and Singapore (GIC), to back its bid,...

Share
bullish•Grifols SA
•22 Aug 2024 21:45

Brookfield/Grifols: Update & Recap, Spread, Discount

Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private...

Share
x